For each of the three paired cancer cell lines, we used gene expression and protein phosphorylation assays to test whether compensatory GF signal-mediated proliferation phenotypes (predicted from scRNAseq analyses of patient tumors) emerged in vitro under endocrine and CDK4/6i treatment. Here, CDK4 is linked to cancer.